Factor XIII Concentrate Mitigates Hemorrhage in Pediatric Extracorporeal Membrane Oxygenation Support With Acquired Factor XIII Deficiency [0.03%]
第十三因子浓缩剂可减轻获得性FXIII缺乏症儿童体外膜氧合支持患者的出血现象
Jun Fujita,Ashish A Ankola,Arun Saini et al.
Jun Fujita et al.
Bleeding is a major complication in patients on extracorporeal membrane oxygenation (ECMO). Acquired factor XIII (FXIII) deficiency develops during ECMO support; however, little is known about the effects of FXIII administration on bleeding...
A Perioperative Blood Conservation Protocol to Achieve Successful Bloodless Heart Transplantation [0.03%]
无输血心脏移植的围手术期用血防护 protocol
Frederick M Lang,Guilherme Marmontel Nasi,Julia Allen et al.
Frederick M Lang et al.
Heart transplantation (HT) is the definitive therapy for end-stage heart failure. Patients unwilling to receive blood product transfusions are often considered ineligible for HT due to the significant perioperative bleeding risk. "Bloodless...
Right-Dominant Fulminant Myocarditis Managed With Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) and Impella Support (EC-PELLA) [0.03%]
右优势型爆发性心肌炎经静脉动脉式体外膜肺氧合(ECMO)及Impella支持（EC-PHELLA）治疗病例报告
Christopher Kocx,Matthew Doyle,Mark Lucey et al.
Christopher Kocx et al.
Fulminant myocarditis may present with rapidly progressive cardiogenic shock and biventricular failure. Although fulminant myocarditis often presents with global left ventricular (LV) failure, unusual right-ventricular-predominant forms can...
Prognosis of Immunocompromised Patients With Respiratory Failure Managed With Venovenous Extracorporeal Membrane Oxygenation [0.03%]
免疫抑制患者的呼吸衰竭体外膜肺氧合静脉至静脉支持的预后研究
Natsumi T Hamahata,Jonathan D Paladino,Makoto Uchiyama et al.
Natsumi T Hamahata et al.
Despite the increasing number of critically ill immunocompromised patients in intensive care unit, the outcome of different types of immunocompromised patients with respiratory failure managed with venovenous extracorporeal membrane oxygena...
A Comparative Analysis of Bivalirudin and Heparin for Extracorporeal Membrane Oxygenation in a Pediatric Cardiothoracic Intensive Care Unit [0.03%]
儿科心血管重症监护病房 ECMO 治疗中比伐卢定与肝素的比较分析
Zachary Daniels,Ashley B Walczak,Eric A Lloyd et al.
Zachary Daniels et al.
Unfractionated heparin has long been the conventional anticoagulant for pediatric mechanical circulatory support (MCS). As bivalirudin has gained traction in ventricular assist devices (VAD) management, its role in extracorporeal membrane o...
Erratum: Neutrophil Structural and Functional Alterations After High Mechanical Shear Stress Exposure [0.03%]
高机械剪切应力暴露后中性粒细胞的结构和功能改变的勘误表
Katherin Arias,Wenji Sun,Dong Han et al.
Katherin Arias et al.
Exploring the Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Left Ventricular Assist Device Patients: Clinical Outcomes in a Multicenter Experience [0.03%]
钠-葡萄糖共转运体2抑制剂在左心室辅助装置患者中的安全性研究：多中心临床经验及预后指标分析
Sonja Hamed,Nikolaos Kalampokas,Jan Beckendorf et al.
Sonja Hamed et al.
Heart failure (HF) remains a progressive condition even with optimal medical therapy, often requiring advanced interventions like left ventricular assist devices (LVAD). Recent advancements in HF treatment, including sodium-glucose co-trans...
Utilization of Hearts Donated After Circulatory Death Improves All-Cause Survival in Candidates With Durable Left Ventricular Assist Devices [0.03%]
donor hearts提高左心室辅助装置植入患者的生存率：回顾性队列研究
Yeahwa Hong,Umar Nasim,Ander Dorken-Gallastegi et al.
Yeahwa Hong et al.
Heart transplantation practices have evolved significantly following the 2018 heart allocation policy changes and the introduction of donation after circulatory death (DCD) heart transplantation in 2019. Under the new system, candidates sup...
Percutaneous Right Ventricular Support via ProtekDuo Pulmonary Artery Cannulation [0.03%]
经ProtekDuo肺动脉导管的右心室辅助支持疗法
Jamila Kremer,Ana Julia Holler,Bastian Schmack et al.
Jamila Kremer et al.
ProtekDuo dual-lumen cannula implantation provides effective percutaneous right ventricular support in acute right heart failure. This retrospective study analyzed 60 patients who received ProtekDuo support for a mean of 14.9 ± 9.7 days. H...
Letter to the Editor Regarding Factors Influencing Recirculation in Veno-Venous Extracorporeal Membrane Oxygenation: Insights From a Controlled Bench Study [0.03%]
写给编辑室关于体外膜氧合静脉循环影响因素的信：来自控制台架研究的见解
Jin Peng,Zhifeng Liang,Jiaye Wang et al.
Jin Peng et al.